(Bloomberg) Babylon, the medical startup that helps diagnose conditions and prescribe treatments online, is exploring options to go public as business booms amid the Covid-19 pandemic, according to people familiar with the matter.The U.K.-based health-care group has been approached by several special purpose acquisition companies about going public via a SPAC merger, the people said. Babylon, which is working with advisers, is also weighing a traditional initial public offering in the U.S., the people said, asking not to be identified discussing confidential information.A listing could value the company at more than $4 billion, according to the people.No final decisions have been made, and details of the potential transaction could change, the people said. A representative for Babylon declined to comment.Babylon was founded in 2013. Its app lets users schedule a video chat with a doctor, check symptoms or book time with specialists, such as therapists. The U.K.’s National Heal ....